Analyst Ratings for GlaxoSmithKline (GSK) [Neutrals]

GSK Rating Summary

GSK Price Target Summary

* Over Last 12-Mos
  |   Expand Research on GSK
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $48.00 (+27%) * Over Last 12-Mos
Rating Score: 3.2 / 10   Percentile Rank: 31%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
2/26/2016 Cantor Fitzgerald New Coverage Hold
(N/A)
N/A
(N/A)
39.50 37.79 -4.33% Details
10/20/2015 Credit Suisse Upgrade Neutral
(Underperform)
N/A
(N/A)
41.74 37.79 -9.46% Details
Like GSK Ratings? Also take a look at PFE, INO, INVA, BMY

GSK Ratings News